Observation vs Progesterone Treatment for Management of Uterine Arteriovenous Malformation
A randomized trial which compares conservative management to progesterone based treatment for arteriovenous malformation
Arteriovenous Malformations
DRUG: MedroxyPROGESTERone Injection [Depo-Provera]|DEVICE: Other
AVM regression, The time from diagnosis to regression, 3 weeks
A randomized trial which compares conservative management to progesterone based treatment for arteriovenous malformation